Research Spotlight

Institutions: Division of Medical Genetics and Metabolism at Massachusetts General Hospital, LuMind IDSC Foundation, the Department…

EXAMINING ADULTS WITH NEUROATYPICAL CONDITIONS FOR MCI/DEMENTIA DURING COGNITIVE IMPAIRMENT ASSESSMENTS: REPORT OF THE NEUROATYPICAL…

January 26, 2022 In a study funded by the LuMind IDSC Foundation, the T21RS COVID-19 Initiative launched an…

January 25, 2022  Recently, two institutions in the Down Syndrome Clinical Trials Network (DS-CTN) published five studies…

Impaired immune function is a clear and growing threat to the health and well-being of…

January 12, 2022 During the past year, LuMind IDSC remained cautiously optimistic about treatment possibilities that…

October 20, 2021 LuMind IDSC, the National Down Syndrome Society (NDSS), and the National Task…

 October 18, 2021 Dr. Nicole White, Hampus Hillerstrom, LuMind IDSC and a team of experts,…

Dr. James Hendrix, LuMind IDSC's Chief Scientific Officer, along with a team of Down syndrome…

October 7, 2021  From mom of four to Down syndrome researcher. Research Spotlight sat with…